Skip to main navigation Skip to search Skip to main content

Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial (Nature Medicine, (2025), 10.1038/s41591-025-04119-2)

  • Jennifer M Kwon*
  • , Francina Munell
  • , Laure Le Goff
  • , Kotaro Yuge
  • , Tamaki Kato
  • , Claude Cances
  • , Liesbeth De Waele
  • , Ian R Woodcock
  • , Eugenio M Mercuri
  • , Crystal M Proud
  • , Basil T Darras
  • , Leslie H Hayes
  • , Maryam Oskoui
  • , Jeannie Visootsak
  • , Gemma Williams
  • , Andreja Ilić
  • , Lina Yang
  • , W Ludo van der Pol
  • *Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

1 Downloads (Pure)

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-025-04119-2, published online 8 December 2025. In the version of the article initially published, in the second paragraph of the “Safety” section, the text “one on the day of gastronomy surgery” has been amended to “one on the day of percutaneous endoscopic gastrostomy” in the HTML and PDF versions of the article.

Original languageEnglish
Pages (from-to)763
Number of pages1
JournalNature medicine
Volume32
Issue number2
Early online date28 Jan 2026
DOIs
Publication statusPublished - Feb 2026

Fingerprint

Dive into the research topics of 'Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial (Nature Medicine, (2025), 10.1038/s41591-025-04119-2)'. Together they form a unique fingerprint.

Cite this